A detailed history of Palisade Capital Management LLC transactions in Danaher Corp stock. As of the latest transaction made, Palisade Capital Management LLC holds 131,640 shares of DHR stock, worth $30.4 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
131,640
Previous 125,000 5.31%
Holding current value
$30.4 Million
Previous $31.2 Million 17.17%
% of portfolio
1.14%
Previous 0.99%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $1.59 Million - $1.86 Million
6,640 Added 5.31%
131,640 $36.6 Million
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $342,431 - $389,642
-1,454 Reduced 1.15%
125,000 $31.2 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $6.27 Million - $7.15 Million
-27,904 Reduced 18.08%
126,454 $31.6 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $601,945 - $758,138
-3,252 Reduced 2.06%
154,358 $35.7 Million
Q3 2023

Nov 14, 2023

SELL
$233.08 - $265.59 $755,412 - $860,777
-3,241 Reduced 2.01%
157,610 $39.1 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $4.66 Million - $5.3 Million
-20,691 Reduced 11.4%
160,851 $38.6 Million
Q1 2023

May 08, 2023

SELL
$239.75 - $277.0 $775,351 - $895,818
-3,234 Reduced 1.75%
181,542 $45.8 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $341,850 - $399,722
-1,416 Reduced 0.76%
184,776 $49.1 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $342,919 - $2.09 Million
-1,388 Reduced 0.74%
186,192 $48.1 Million
Q2 2022

Aug 10, 2022

SELL
$237.11 - $299.66 $1.08 Million - $1.37 Million
-4,573 Reduced 2.38%
187,580 $47.6 Million
Q1 2022

May 09, 2022

BUY
$257.27 - $315.76 $304,350 - $373,544
1,183 Added 0.62%
192,153 $56.4 Million
Q4 2021

Feb 10, 2022

SELL
$292.08 - $329.01 $375,030 - $422,448
-1,284 Reduced 0.67%
190,970 $62.8 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $2.93 Million - $3.58 Million
-10,755 Reduced 5.3%
192,254 $58.5 Million
Q2 2021

Aug 12, 2021

BUY
$225.08 - $271.69 $164,983 - $199,148
733 Added 0.36%
203,009 $54.5 Million
Q1 2021

May 12, 2021

BUY
$212.38 - $245.9 $2.59 Million - $2.99 Million
12,178 Added 6.41%
202,276 $45.5 Million
Q4 2020

Feb 11, 2021

SELL
$212.5 - $245.46 $3.73 Million - $4.31 Million
-17,551 Reduced 8.45%
190,098 $42.2 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $944,794 - $1.15 Million
-5,333 Reduced 2.5%
207,649 $44.7 Million
Q2 2020

Aug 06, 2020

BUY
$128.7 - $176.83 $598,455 - $822,259
4,650 Added 2.23%
212,982 $37.7 Million
Q1 2020

May 13, 2020

SELL
$121.39 - $169.05 $1.57 Million - $2.18 Million
-12,924 Reduced 5.84%
208,332 $28.8 Million
Q4 2019

Feb 04, 2020

BUY
$133.47 - $153.48 $327,268 - $376,332
2,452 Added 1.12%
221,256 $34 Million
Q3 2019

Nov 06, 2019

BUY
$135.4 - $146.47 $266,331 - $288,106
1,967 Added 0.91%
218,804 $31.6 Million
Q2 2019

Aug 06, 2019

SELL
$124.88 - $143.73 $13,736 - $15,810
-110 Reduced 0.05%
216,837 $31 Million
Q1 2019

May 13, 2019

BUY
$97.62 - $132.29 $436,459 - $591,468
4,471 Added 2.1%
216,947 $28.6 Million
Q4 2018

Feb 12, 2019

SELL
$94.85 - $109.54 $71,232 - $82,264
-751 Reduced 0.35%
212,476 $21.9 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $180,853 - $200,702
1,843 Added 0.87%
213,227 $23.2 Million
Q2 2018

Aug 13, 2018

BUY
$96.1 - $103.24 $52,182 - $56,059
543 Added 0.26%
211,384 $20.9 Million
Q1 2018

May 09, 2018

BUY
$92.16 - $103.8 $207,544 - $233,757
2,252 Added 1.08%
210,841 $20.6 Million
Q4 2017

Feb 09, 2018

SELL
$85.26 - $94.62 $166,853 - $185,171
-1,957 Reduced 0.93%
208,589 $19.4 Million
Q3 2017

Oct 31, 2017

BUY
$79.29 - $88.45 $16.7 Million - $18.6 Million
210,546
210,546 $18.1 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.